首页 | 本学科首页   官方微博 | 高级检索  
检索        

Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease
引用本文:Barta Z,Csíp? I,Szabó GG,Szegedi G.Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease[J].世界胃肠病学杂志(英文版),2003,9(10):2308-2312.
作者姓名:Barta Z  Csípõ I  Szabó GG  Szegedi G
摘    要:AIM: To explore whether there was anti-Saccharomyces cerevisiae antibodies (ASCA) positivity in our patients with biopsy-confirmed celiac disease. METHODS: A cohort of patients with inflammatory bowel diseases (42 patients with Crohn‘‘s disease and 10 patients with ulcerative colitis) and gluten sensitive enteropathy (16 patients) from Debrecen, Hungary were enrolled in the study.The diagnosis was made using the formally accepted criteria.Perinuclear antineutrophil cytoplasmic antibodies (pANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA),antiendomysium antibodies (EMA), antigliadin antibodies(AGA) and anti human tissue transglutaminase antibodies(tTGA) were investigated.RESULTS: The results showed that ASCA positivity occurred not only in Crohn‘‘s disease but also in Celiac disease and in these cases both the IgG and IgA type antibodies were proved.CONCLUSION: It is conceivable that ASCA positivity correlates with the (auto-) immune inflammation of small intestines and it is a specific marker of Crohn‘‘s disease.

关 键 词:克隆病  腹部疾病  酵母菌  pANCA  抗体  炎症
收稿时间:2003 Mar 12

Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease
Barta Zsolt,Csíp? István,Szabó Gábor G,Szegedi Gyula.Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease[J].World Journal of Gastroenterology,2003,9(10):2308-2312.
Authors:Barta Zsolt  Csípõ István  Szabó Gábor G  Szegedi Gyula
Institution:3rd Dept. of Medicine, University of Debrecen, Moricz Zs. Krt.22. 4004 Debrecen, Hungary. barta@iiibel.dote.hu
Abstract:AIM: To explore whether there was anti-Saccharomyces cerevisiae antibodies (ASCA) positivity in our patients with biopsy-confirmed celiac disease. METHODS: A cohort of patients with inflammatory bowel diseases (42 patients with Crohn's disease and 10 patients with ulcerative colitis) and gluten sensitive enteropathy (16 patients) from Debrecen, Hungary were enrolled in the study. The diagnosis was made using the formally accepted criteria. Perinuclear antineutrophil cytoplasmic antibodies (pANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA), antiendomysium antibodies (EMA), antigliadin antibodies (AGA) and anti human tissue transglutaminase antibodies (tTGA) were investigated. RESULTS: The results showed that ASCA positivity occurred not only in Crohn's disease but also in Celiac disease and in these cases both the IgG and IgA type antibodies were proved. CONCLUSION: It is conceivable that ASCA positivity correlates with the (auto-) immune inflammation of small intestines and it is a specific marker of Crohn's disease.
Keywords:
本文献已被 维普 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号